Andrea Uecker Selected Research

Kalinin

1/2011

EGF/TGFβ1 co-stimulation of oral squamous cell carcinoma cells causes an epithelial-mesenchymal transition cell phenotype expressing laminin 332.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Uecker Research Topics

Disease

2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2009 - 06/2006
1	Squamous Cell Carcinoma of Head and Neck 01/2011
1	Neoplasms (Cancer) 09/2010
1	Neointima 01/2010
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2010
1	Fibrosis (Cirrhosis) 07/2008
1	Myocarditis (Carditis) 07/2008

Drug/Important Bio-Agent (IBA)

2	Imatinib Mesylate (Gleevec)FDA Link 09/2010 - 07/2008
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2010 - 07/2008
2	Phosphotransferases (Kinase)IBA 01/2010 - 07/2008
1	Epidermal Growth Factor (EGF)IBA 01/2011
1	Messenger RNA (mRNA)IBA 01/2011
1	KalininIBA 01/2011
1	Laminin (Merosin)IBA 01/2011
1	VimentinIBA 01/2011
1	Histone Deacetylase InhibitorsIBA 09/2010
1	Tyrosine Kinase InhibitorsIBA 09/2010
1	Pharmaceutical PreparationsIBA 01/2009
1	fms-Like Tyrosine Kinase 3IBA 01/2009
1	Hydroxyproline (4 Hydroxyproline)IBA 07/2008
1	platelet-derived growth factor AIBA 07/2008
1	Platelet-Derived Growth FactorIBA 07/2008
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2006

Therapy/Procedure

2	Therapeutics 09/2010 - 01/2010
1	Stents 01/2010